Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

101.07
-0.2000-0.20%
Post-market: 101.070.00000.00%19:30 EDT
Volume:99.78K
Turnover:10.11M
Market Cap:1.62B
PE:9.41
High:102.12
Open:101.96
Low:101.00
Close:101.27
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:0.68
T/O Rate:0.62%
Dividend:1.47
Dividend Rate:1.45%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Yesterday

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Dow Jones
·
Yesterday

BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod

TIPRANKS
·
Yesterday

Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors

TIPRANKS
·
Yesterday

Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors

TIPRANKS
·
Yesterday

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says

MT Newswires Live
·
Yesterday

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Reuters
·
Sep 10

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Reuters
·
Sep 10

Bristol-Myers Squibb is Maintained at Hold by HSBC

Dow Jones
·
Sep 10

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

Bloomsbury Executives Adjust Holdings After 2023 Share Plan Vesting

TIPRANKS
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)

TIPRANKS
·
Sep 09

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

BRAIN Biotech Receives EUR 11.51 Million Milestone Payment from Royalty Pharma

Reuters
·
Sep 09

Leerink Partners Adjusts Price Target on Merck & Co. to $161 From $127, Keeps Outperform Rating

MT Newswires Live
·
Sep 09